Heron Therapeutics, Inc. · NASDAQ:HRTX
Duarte Ira exercised options for 3,874 Heron Therapeutics, Inc. shares (Form 4)
Traded Oct 19, 2026 · Filed Oct 21, 2026
On Oct 19, 2026, Duarte Ira (EVP, Chief Financial Officer) exercised options for 3,874 Heron Therapeutics, Inc. shares, leaving 284,671 shares. Filed Oct 21, 2026 (Form 4).
- Options exercised
- 3,874 shares
- Holding after
- 284,671 shares
- Trading plan
- No
- Role
- EVP, Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 19, 2026 | Common Stock | Option exercise | 3,874 | 285,773 | Direct | |
| Oct 19, 2026 | Common Stock | Shares withheld for tax | 1,102 | US$0.36 | 284,671 | Direct |
Source
Download original · View original at SEC
Related
- Heron Therapeutics, Inc.
- Duarte Ira
- Heron Therapeutics, Inc. shareholders
- Form 4 · Duarte Ira · Aug 3, 2026
- Form 4 · Duarte Ira · Jul 20, 2026
- Form 4 · Duarte Ira · Jun 17, 2026
- Form 4 · Duarte Ira · May 4, 2026
- Form 4 · Duarte Ira · Apr 21, 2026
- Form 4 · Collard Craig A · Oct 21, 2026
- Form 4 · Forbes William P · Oct 21, 2026
- Form 4 · Hensley Mark Earl · Aug 10, 2026
- Form 4 · Hensley Mark Earl · Aug 3, 2026
- Form 4 · Forbes William P · Aug 3, 2026